Tareq Abadl: Massive Transfusion – The Hidden Citrate Risk
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
“Did you know that during massive transfusion, one hidden danger is not the blood type – but the anticoagulant inside the blood bag?
Blood components are stored with citrate to prevent clotting.
During massive transfusion, large amounts of citrate can bind calcium and magnesium in the patient’s bloodstream, leading to citrate toxicity and hypocalcemia.
Why does this matter?
Because calcium is critical for:
- Cardiac contractility
- Coagulation pathways
- Neuromuscular function
- Cellular stability.
When citrate accumulates faster than the body can metabolize it, patients may develop:
- Hypotension
- Reduced ventricular function
- Arrhythmias
- Coagulopathy
- Tetany or increased neuromuscular excitability.
Under normal conditions, citrate is rapidly metabolized through the Krebs cycle, mainly by the liver, kidneys, and skeletal muscle. But in trauma, shock, hypothermia, liver dysfunction, or poor tissue perfusion, citrate clearance decreases significantly – making toxicity more likely during rapid transfusion.
An important point in transfusion medicine:
- Hypocalcemia in massive transfusion is often dilutional and citrate-related at the same time.
That is why modern Massive Transfusion Protocols (MTPs) emphasize:
- Monitoring ionized calcium
- Early calcium replacement
- Close assessment of coagulation and electrolytes
Prevention of the ‘lethal triad’:
- Hypothermia
- Coagulopathy
- Acidosis.
Another interesting blood bank fact:
- Plasma and platelets usually contain more citrate than packed RBCs, so the risk may increase when large amounts of these components are transfused rapidly.
This is a powerful reminder that transfusion safety is not only about ABO and Rh compatibility.
Blood bank science also involves understanding metabolic, electrolyte, and coagulation complications during emergency transfusion support.”
Other posts featuring Tareq Abadl on Hemostasis Today.
-
Jun 25, 2026, 10:49Onisillos Sekkides: Quantifying Maternal IgG Against Group B Streptococcus Alpha-Like Proteins in Neonates
-
Jun 25, 2026, 05:26Paola Mendez Hiraldo: Glenn Ruperto’s Stroke Recovery and the Power of Team-Based Care
-
Jun 25, 2026, 05:19Steven Bell: Lessons in Rapid Stroke Care from Vall d’Hebron University Hospital
-
Jun 25, 2026, 04:48Brianne Martin: Stroke Recovery Is More Than Medical Appointments
-
Jun 24, 2026, 22:30The Clinical Impact of Anaphylaxis-Associated Coagulopathy – JTH
-
Jun 24, 2026, 21:08Martin Haluzík: Semaglutide as a Strategy for Primary Prevention of Cerebrovascular Disease in RA
-
Jun 24, 2026, 19:43New ASH/ISTH 2026 Guidelines for Pediatric Anticoagulant Prophylaxis of VTE Are Now Live – Blood Journals Portfolio
-
Jun 24, 2026, 18:36Maryam Sardar: Timely Anticoagulation in SMV Thrombosis Complicating Acute Pancreatitis
-
Jun 24, 2026, 17:36Paul Whiteley: Neurodevelopmental and Autism Risks in Fetal and Neonatal Alloimmune Thrombocytopenia